The evaluation of national time trends, quality of care, and factors affecting the use of minimally invasive breast biopsy and open biopsy for diagnosis of breast lesions - 14/08/14
Abstract |
Background |
Minimally invasive breast biopsy is a recommended biopsy method for suspicious lesions. This study examines national trends and factors associated with the use of open breast biopsy (OBB).
Methods |
The national inpatient sample database was used to examine trends and factors associated with the use of OBB. Factors associated with OBB were evaluated using chi-square test for univariate analysis and logistic regression for multivariate analysis.
Results |
OBB rate was 34%. Patients below 50 years of age had OBB rates of 47%, while those above 50 had OBB rates of 29.1% (P < .001). Higher OBB rates were observed in Asian (39.8%) and Hispanic (40.6%) women compared with white women (34.1%, P < .001). Private insurance patients were more likely to have OBB compared with Medicaid/Medicare patients (40.9% vs 30.6%, P < .001). About 1.2% of women who underwent OBB required multiple biopsies for diagnosis compared with .5% for minimally invasive breast biopsy (P < .001).
Conclusions |
OBB is still performed in one third of women despite higher morbidity and less accuracy. Factors associated with higher OBB rate included younger age; Asian ethnicity; private insurance; small, rural, and nonteaching hospitals.
Le texte complet de cet article est disponible en PDF.Keywords : Open breast biopsy, Minimally invasive breast biopsy, Breast cancer
Plan
| No current or previous support was received from industry or organizations. |
Vol 208 - N° 3
P. 382-390 - septembre 2014 Retour au numéro
Article précédent
- Transanal minimally invasive surgery for benign and malignant rectal neoplasia
- Elisabeth C. McLemore, Lynn A. Weston, Alisa M. Coker, Garth R. Jacobsen, Mark A. Talamini, Santiago Horgan, Sonia L. Ramamoorthy
- Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymphadenectomy for advanced gastric cancer
- Cheng Fang, Jin Hua, Jipeng Li, Jianyong Zhen, Fei Wang, Qingchuan Zhao, Jianbo Shuang, Jianjun Du
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?